John Y. Caloz
2023
In 2023, John Y. Caloz earned a total compensation of $416K as Chief Financial Officer, Treasurer and Senior Vice President at CytRx, a 17% decrease compared to previous year.
Compensation breakdown
| Salary | $416,000 |
|---|---|
| Total | $416,000 |
Caloz received $416K in salary, accounting for 100% of the total pay in 2023.
Rankings
In 2023, John Y. Caloz's compensation ranked 2,240th out of 3,006 executives tracked by ExecPay. In other words, Caloz earned more than 25.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,240 out of 3,006 | 26th |
Division Manufacturing | 1,272 out of 1,650 | 23rd |
Major group Chemicals And Allied Products | 763 out of 918 | 17th |
Industry group Drugs | 745 out of 881 | 15th |
Industry Biological Products, Except Diagnostic Substances | 188 out of 213 | 12th |
Source: SEC filing on August 20, 2024.
Caloz's colleagues
We found one more compensation record of an executive who worked with John Y. Caloz at CytRx in 2023.
2023
Stephen Snowdy
CytRx
Chief Executive Officer
News
CytRx CEO Stephen Snowdy's 2023 pay slips 3% to $545K
August 20, 2024
CytRx CEO Stephen Snowdy receives $563K in 2022
July 28, 2023
CytRx CEO Steven Kriegsman's 2021 pay jumps 592% to $7M
June 16, 2022
CytRx CEO Steven Kriegsman's 2020 pay falls 41% to $1M
June 14, 2021
CytRx CEO Steven Kriegsman's 2019 pay jumps 68% to $1.7M
June 12, 2020
CytRx CEO Steven Kriegsman's 2018 pay falls 48% to $1M
June 26, 2019